{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T10:55:38Z","timestamp":1793012138863,"version":"4.5.0"},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Recent studies have demonstrated that pathological analysis of retroperitoneal residual masses of patients with testicular germ cell tumors revealed findings of necrotic debris or fibrosis in up to 50% of patients. We aimed at pursuing a clinical and pathological review of patients undergoing post chemotherapy retroperitoneal lymph node dissection (PC-RPLND) in order to identify variables that may help predict necrosis in the retroperitoneum.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We performed a retrospective analysis of all patients who underwent PC-RPLND at the University Hospital of the University of S\u00e3o Paulo and Cancer Institute of Sao Paulo between January 2005 and September 2011. Clinical and pathological data were obtained and consisted basically of: measures of retroperitoneal masses, histology of the orchiectomy specimen, serum tumor marker and retroperitoneal nodal size before and after chemotherapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>We gathered a total of 32 patients with a mean age of 29.7; pathological analysis in our series demonstrated that 15 (47%) had necrosis in residual retroperitoneal masses, 15 had teratoma (47%) and 2 (6.4%) had viable germ cell tumors (GCT). The mean size of the retroperitoneal mass was 4.94 cm in our sample, without a difference between the groups (<jats:italic>P<\/jats:italic>\u2009=\u20090.176). From all studied variables, relative changes in retroperitoneal lymph node size (<jats:italic>P<\/jats:italic>\u2009=\u20090.04), the absence of teratoma in the orchiectomy specimen (<jats:italic>P<\/jats:italic>\u2009=\u20090.03) and the presence of choriocarcinoma in the testicular analysis after orchiectomy (<jats:italic>P<\/jats:italic>\u2009=\u20090.03) were statistically significant predictors of the presence of necrosis. A reduction level of 35% was therefore suggested to be the best cutoff for predicting the absence of tumor in the retroperitoneum with a sensitivity of 73.3% and specificity of 82.4%.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Even though retroperitoneal lymph node dissection remains the gold standard for patients with residual masses, those without teratoma in the primary tumor and a shrinkage of 35% or more in retroperitoneal mass have a considerably smaller chance of having viable GCT or teratoma in the retroperitoneum and a surveillance program could be considered.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1477-7819-10-203","type":"journal-article","created":{"date-parts":[[2012,9,30]],"date-time":"2012-09-30T17:14:04Z","timestamp":1349025244000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Predicting necrosis in residual mass analysis after retroperitoneal lymph node dissection: a retrospective study"],"prefix":"10.1186","volume":"10","author":[{"given":"Eduardo de Paula","family":"Miranda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel Kanda","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano Jo\u00e3o","family":"Nesrallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina Thalita","family":"dos Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandre","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Srougi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Francisco","family":"Dall\u2019Oglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,9,28]]},"reference":[{"key":"1125_CR1","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/107327480200900402","volume":"9","author":"R Foster","year":"2002","unstructured":"Foster R, Bihrle R: Current status of retroperitoneal lymph node dissection and testicular cancer: when to operate. Cancer Control. 2002, 9: 277-283.","journal-title":"Cancer Control"},{"key":"1125_CR2","doi-asserted-by":"publisher","first-page":"1583","DOI":"10.1136\/bmj.322.7302.1583","volume":"322","author":"D Dearnaley","year":"2001","unstructured":"Dearnaley D, Huddart R, Horwich A: Regular review: managing testicular cancer. BMJ. 2001, 322: 1583-1588. 10.1136\/bmj.322.7302.1583.","journal-title":"BMJ"},{"key":"1125_CR3","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/1477-7819-8-97","volume":"8","author":"AM Luz","year":"2010","unstructured":"Luz AM, Kotb AF, Aldousari S, Brimo F, Tanguay S, Kassouf W, Aprikian AG: Retroperitoneal lymph node dissection for residual masses after chemotherapy in nonseminomatous germ cell testicular tumor. World J Surg Oncol. 2010, 8: 97. 10.1186\/1477-7819-8-97.","journal-title":"World J Surg Oncol"},{"key":"1125_CR4","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1200\/JCO.1995.13.5.1177","volume":"13","author":"EW Steyerberg","year":"1995","unstructured":"Steyerberg EW, Keizer HJ, Fossa SD, Sleijfer DT, Toner GC, SchraffordtKoops H, Mulders PF, Messemer JE, Ney K, Donohue JP: Prediction of residual retroperitoneal mass histology after chemotherapy for metastatic nonseminomatous germ cell tumor: multivariate analysis of individual patient data from six study groups. J Clin Oncol. 1995, 13: 1177-1187.","journal-title":"J Clin Oncol"},{"key":"1125_CR5","doi-asserted-by":"publisher","first-page":"325","DOI":"10.2214\/ajr.151.2.325","volume":"151","author":"JG Lorigan","year":"1988","unstructured":"Lorigan JG, Eftekhari F, David CL, Shirkhoda A: The growing teratoma syndrome: an unusual manifestation of treated, nonseminomatous germ cell tumors of the testis. AJR Am J Roentgenol. 1988, 151: 325-329.","journal-title":"AJR Am J Roentgenol"},{"key":"1125_CR6","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/bjc.1984.226","volume":"50","author":"D Tait","year":"1984","unstructured":"Tait D, Peckham MJ, Hendry WF, Goldstraw P: Post-chemotherapy surgery in advanced non-seminomatous germ-cell testicular tumours: the significance of histology with particular reference to differentiated (mature) teratoma. Br J Cancer. 1984, 50: 601-609. 10.1038\/bjc.1984.226.","journal-title":"Br J Cancer"},{"key":"1125_CR7","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1200\/JCO.2001.19.10.2647","volume":"19","author":"K Fizazi","year":"2001","unstructured":"Fizazi K, Tjulandin S, Salvioni R, Germ\u00e0-Lluch JR, Bouzy J, Ragan D, Bokemeyer C, Gerl A, Fl\u00e9chon A, de Bono JS, Stenning S, Horwich A, Pont J, Albers P, De Giorgi U, Bower M, Bulanov A, Pizzocaro G, Aparicio J, Nichols CR, Th\u00e9odore C, Hartmann JT, Schmoll HJ, Kaye SB, Culine S, Droz JP, Mah\u00e9 C: Viable malignant cells after primary chemotherapy for disseminated nonseminomatous germ cell tumors: prognostic factors and role of postsurgery chemotherapy\u2013results from an international study group. J Clin Oncol. 2001, 19: 2647-2657.","journal-title":"J Clin Oncol"},{"key":"1125_CR8","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/S0022-5347(01)64035-7","volume":"159","author":"RJ Motzer","year":"1998","unstructured":"Motzer RJ, Amsterdam A, Prieto V, Sheinfeld J, Murty VV, Mazumdar M, Bosl GJ, Chaganti RS, Reuter VE: Teratoma with malignant transformation: diverse malignant histologies arising in men with germ cell tumors. J Urol. 1998, 159: 133-138. 10.1016\/S0022-5347(01)64035-7.","journal-title":"J Urol"},{"key":"1125_CR9","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/S0022-5347(06)00508-8","volume":"176","author":"BS Carver","year":"2006","unstructured":"Carver BS, Bianco FJ, Shayegan B, Vickers A, Motzer RJ, Bosl GJ, Sheinfeld J: Predicting teratoma in the retroperitoneum in men undergoing post-chemotherapy retroperitoneal lymph node dissection. J Urol. 2006, 176: 100-103. 10.1016\/S0022-5347(06)00508-8.","journal-title":"J Urol"},{"key":"1125_CR10","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1590\/S1677-55382004000500005","volume":"30","author":"S El Sayed","year":"2004","unstructured":"El Sayed S, Grando JP, Almeida SH, MortatiNeto N, Moreira HA: Post-chemotherapy residual mass in non-seminomatous testicular cancer. The role of retroperitoneal lymph node dissection. Int Braz J Urol. 2004, 30: 384-388. 10.1590\/S1677-55382004000500005.","journal-title":"Int Braz J Urol"},{"key":"1125_CR11","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1111\/j.1464-410X.2007.06740.x","volume":"99","author":"B Shayegan","year":"2007","unstructured":"Shayegan B, Carver BS, Stasi J, Motzer RJ, Bosl GJ, Sheinfeld J: Clinical outcome following post-chemotherapy retroperitoneal lymph node dissection in men with intermediate- and poor-risk nonseminomatous germ cell tumour. BJU Int. 2007, 99: 993-997. 10.1111\/j.1464-410X.2007.06740.x.","journal-title":"BJU Int"},{"key":"1125_CR12","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1053\/suro.2002.36977","volume":"20","author":"J Sheinfeld","year":"2002","unstructured":"Sheinfeld J: The role of adjunctive postchemotherapy surgery for nonseminomatous germ-cell tumors: current concepts and controversies. Semin Urol Oncol. 2002, 20: 262-271. 10.1053\/suro.2002.36977.","journal-title":"Semin Urol Oncol"},{"key":"1125_CR13","doi-asserted-by":"publisher","first-page":"1377","DOI":"10.1093\/annonc\/mdh301","volume":"15","author":"HJ Schmoll","year":"2004","unstructured":"Schmoll HJ, Souchon R, Krege S, Albers P, Beyer J, Kollmannsberger C, Fossa SD, Skakkebaek NE, de Wit R, Fizazi K, Droz JP, Pizzocaro G, Daugaard G, de Mulder PH, Horwich A, Oliver T, Huddart R, Rosti G, Paz Ares L, Pont O, Hartmann JT, Aass N, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Classen J, Clemm S, Culine S, de Wit M: European consensus on diagnosis and treatment of germ cell cancer: a report of the European germ cell cancer consensus group (EGCCCG). Ann Oncol. 2004, 15: 1377-1399. 10.1093\/annonc\/mdh301.","journal-title":"Ann Oncol"},{"key":"1125_CR14","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1200\/JCO.2003.03.184","volume":"21","author":"J Oldenburg","year":"2003","unstructured":"Oldenburg J, Alfsen GC, Lien HH, Aass N, Waehre H, Fossa SD: Postchemotherapy retroperitoneal surgery remains necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses. J Clin Oncol. 2003, 21: 3310-3317. 10.1200\/JCO.2003.03.184.","journal-title":"J Clin Oncol"},{"key":"1125_CR15","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s00345-009-0452-7","volume":"27","author":"SD Beck","year":"2009","unstructured":"Beck SD, Foster RS: Management of the post chemotherapy subcentimeter residual mass: the case for observation. World J Urol. 2009, 27: 485-488. 10.1007\/s00345-009-0452-7.","journal-title":"World J Urol"},{"key":"1125_CR16","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1016\/S0022-5347(17)44439-9","volume":"137","author":"JP Donohue","year":"1987","unstructured":"Donohue JP, Rowland RG, Kopecky K, Steidle CP, Geier G, Ney KG, Einhorn L, Williams S, Loehrer P: Correlation of computerized tomographic changes and histological findings in 80 patients having radical retroperitoneal lymph node dissection after chemotherapy for testis cancer. J Urol. 1987, 137: 1176-1179.","journal-title":"J Urol"},{"key":"1125_CR17","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1097\/01.ju.0000101513.64777.f2","volume":"171","author":"N Nicolai","year":"2004","unstructured":"Nicolai N, Miceli R, Artusi R, Piva L, Pizzocaro G, Salvioni R: A simple model for predicting nodal metastasis in patients with clinical stage I nonseminomatous germ cell testicular tumors undergoing retroperitoneal lymph node dissection only. J Urol. 2004, 171: 172-176. 10.1097\/01.ju.0000101513.64777.f2.","journal-title":"J Urol"},{"key":"1125_CR18","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1200\/JCO.1992.10.4.569","volume":"10","author":"SD Fossa","year":"1992","unstructured":"Fossa SD, Qvist H, Stenwig AE, Lien HH, Ous S, Giercksky KE: Is postchemotherapy retroperitoneal surgery necessary in patients with nonseminomatous testicular cancer and minimal residual tumor masses?. J Clin Oncol. 1992, 10: 569-573.","journal-title":"J Clin Oncol"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1477-7819-10-203.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:23:44Z","timestamp":1630527824000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/1477-7819-10-203"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,9,28]]},"references-count":18,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["1125"],"URL":"https:\/\/doi.org\/10.1186\/1477-7819-10-203","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,9,28]]},"assertion":[{"value":"29 November 2011","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"203"}}